Carregant...
New treatment option for ovarian cancer: PARP inhibitors
Poly(ADP-ribose) polymerase (PARP), which was first described over 50 years ago by Mandel, are a family of protein enzymes involved in DNA damage response and works by recognizing the single-strand DNA break (ssDNA) and then effecting DNA repair. A double-strand DNA (dsDNA) break can be repaired by...
Guardat en:
| Publicat a: | Gynecol Oncol Res Pract |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4880823/ https://ncbi.nlm.nih.gov/pubmed/27231574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40661-016-0024-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|